Family · Pharmaceutical analytical standards
Cefpodoxime
A third-generation oral cephalosporin, taken as a prodrug (cefpodoxime proxetil) for ear, throat, sinus and other infections; patented in 1980 and approved in 1989. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is also approved in veterinary medicine: in the United States it is used as tablets for skin infections in dogs.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
